Search Results

There are 7593 results for: content related to: Body composition, bone mineral density and fractures in late postmenopausal women with polycystic ovary syndrome – a long-term follow-up study

  1. You have free access to this content
    Vitamin D in the aetiology and management of polycystic ovary syndrome

    Clinical Endocrinology

    Volume 77, Issue 3, September 2012, Pages: 343–350, Rebecca L. Thomson, Simon Spedding and Jonathan D. Buckley

    Article first published online : 14 AUG 2012, DOI: 10.1111/j.1365-2265.2012.04434.x

  2. Influence of race/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study

    Clinical Endocrinology

    Alice Y. Chang, June Oshiro, Colby Ayers and Richard J. Auchus

    Article first published online : 24 DEC 2015, DOI: 10.1111/cen.12986

  3. Prevalence of metabolic syndrome in women with polycystic ovary syndrome

    Clinical Endocrinology

    Volume 78, Issue 4, April 2013, Pages: 586–592, Dimitrios Panidis, Djuro Macut, Konstantinos Tziomalos, Efstathios Papadakis, Konstantinos Mikhailidis, Eleni A. Kandaraki, Elena A. Tsourdi, Theoharis Tantanasis, George Mavromatidis and Ilias Katsikis

    Article first published online : 12 MAR 2013, DOI: 10.1111/cen.12008

  4. You have free access to this content
    Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins

    Clinical Endocrinology

    Volume 81, Issue 6, December 2014, Pages: 899–906, Samantha Cassar, Helena J. Teede, Lisa J. Moran, Anju E. Joham, Cheryce L. Harrison, Boyd J. Strauss and Nigel K. Stepto

    Article first published online : 1 SEP 2014, DOI: 10.1111/cen.12557

  5. Biomarkers and insulin sensitivity in women with Polycystic Ovary Syndrome: Characteristics and predictive capacity

    Clinical Endocrinology

    Volume 83, Issue 1, July 2015, Pages: 50–58, Samantha Cassar, Helena J. Teede, Cheryce L. Harrison, Anju E. Joham, Lisa J. Moran and Nigel K. Stepto

    Article first published online : 7 NOV 2014, DOI: 10.1111/cen.12619

  6. IL-1 receptor antagonist levels are associated with glucose tolerance in polycystic ovary syndrome

    Clinical Endocrinology

    Kari Luotola, Terhi T. Piltonen, Johanna Puurunen and Juha S. Tapanainen

    Article first published online : 26 APR 2016, DOI: 10.1111/cen.13077

  7. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome

    Clinical Endocrinology

    Volume 80, Issue 3, March 2014, Pages: 432–438, Dimitrios Panidis, Konstantinos Tziomalos, Efstathios Papadakis, Panagiotis Chatzis, Eleni A. Kandaraki, Elena A. Tsourdi and Ilias Katsikis

    Article first published online : 28 AUG 2013, DOI: 10.1111/cen.12305

  8. Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance

    Clinical Endocrinology

    Volume 83, Issue 6, December 2015, Pages: 812–819, Elisabeth A. Lambert, Helena Teede, Carolina Ika Sari, Eveline Jona, Soulmaz Shorakae, Kiri Woodington, Robyn Hemmes, Nina Eikelis, Nora E. Straznicky, Barbora De Courten, John B. Dixon, Markus P. Schlaich and Gavin W. Lambert

    Article first published online : 13 MAY 2015, DOI: 10.1111/cen.12803

  9. You have free access to this content
    The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?

    Clinical Endocrinology

    Volume 77, Issue 6, December 2012, Pages: 791–801, Andrew Lansdown and D. Aled Rees

    Article first published online : 9 NOV 2012, DOI: 10.1111/cen.12003

  10. Prescription of antidepressants is increased in Danish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population-based cohort study

    Clinical Endocrinology

    Volume 80, Issue 6, June 2014, Pages: 884–889, M. L. Altinok, D. Glintborg, R. dePont Christensen, J. Hallas and M. Andersen

    Article first published online : 5 DEC 2013, DOI: 10.1111/cen.12365

  11. Serum levels of TSP-1, NF-κB and TGF-β1 in polycystic ovarian syndrome (PCOS) patients in northern China suggest PCOS is associated with chronic inflammation

    Clinical Endocrinology

    Volume 83, Issue 6, December 2015, Pages: 913–922, Meimei Liu, Jiayin Gao, Yanhua Zhang, Peiling Li, Hongli Wang, Xiaopang Ren and Changmin Li

    Article first published online : 19 OCT 2015, DOI: 10.1111/cen.12951

  12. The association between Polycystic Ovary Syndrome (PCOS) and metabolic syndrome: a statistical modelling approach

    Clinical Endocrinology

    Volume 83, Issue 6, December 2015, Pages: 879–887, S. Ranasinha, A.E. Joham, R.J. Norman, J.E. Shaw, S. Zoungas, J. Boyle, L. Moran and H.J. Teede

    Article first published online : 8 JUL 2015, DOI: 10.1111/cen.12830

  13. Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studies

    Clinical Endocrinology

    Volume 78, Issue 3, March 2013, Pages: 438–446, Victoria S. Sprung, Greg Atkinson, Daniel J. Cuthbertson, Christopher J. A. Pugh, Nabil Aziz, Daniel J. Green, N. Timothy Cable and Helen Jones

    Article first published online : 25 JAN 2013, DOI: 10.1111/j.1365-2265.2012.04490.x

  14. Polycystic ovary syndrome is not associated with polymorphisms of the TCF7L2,CDKAL1,HHEX,KCNJ11,FTO and SLC30A8 genes

    Clinical Endocrinology

    Volume 77, Issue 3, September 2012, Pages: 439–445, Jin Ju Kim, Young Min Choi, Young Min Cho, Min A. Hong, Soo Jin Chae, Kyu Ri Hwang, Seung Sik Hwang, Sang Ho Yoon and Shin Yong Moon

    Article first published online : 14 AUG 2012, DOI: 10.1111/j.1365-2265.2012.04389.x

  15. Polycystic Ovary Syndrome: A Common But Often Unrecognized Condition

    Journal of Midwifery & Women’s Health

    Volume 57, Issue 3, May/June 2012, Pages: 221–230, Maureen Shannon and Yusharn Wang

    Article first published online : 18 MAY 2012, DOI: 10.1111/j.1542-2011.2012.00161.x

  16. A comparison of cardiovascular risk indices in patients with polycystic ovary syndrome with and without coexisting nonalcoholic fatty liver disease

    Clinical Endocrinology

    Volume 80, Issue 6, June 2014, Pages: 843–849, Alison J. Dawson, Thozhukat Sathyapalan, Jacqueline A. J. Smithson, Rebecca V. Vince, Anne-Marie Coady, Ramzi Ajjan, Eric S. Kilpatrick and Stephen L. Atkin

    Article first published online : 26 AUG 2013, DOI: 10.1111/cen.12258

  17. Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity

    Clinical Endocrinology

    Volume 79, Issue 2, August 2013, Pages: 252–258, H. Kahal, A. Aburima, T. Ungvari, A. S. Rigby, A. J. Dawson, A. M. Coady, R. V. Vince, R. A. Ajjan, E. S. Kilpatrick, K. M. Naseem and S. L. Atkin

    Article first published online : 11 MAY 2013, DOI: 10.1111/cen.12137

  18. The association of thiol/disulphide homeostasis and lipid accumulation index with cardiovascular risk factors in overweight adolescents with polycystic ovary syndrome

    Clinical Endocrinology

    Volume 84, Issue 4, April 2016, Pages: 516–523, Sibel Ozler, Efser Oztas, Aytekin Tokmak, Merve Ergin, Esra Isci, Funda Eren, Selcen Pehlivan, Salim Neselioglu and Nafiye Yılmaz

    Article first published online : 25 NOV 2015, DOI: 10.1111/cen.12965

  19. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

    Intervention Review

    The Cochrane Library

    Thomas Tang, Jonathan M Lord, Robert J Norman, Ephia Yasmin and Adam H Balen

    Published Online : 16 MAY 2012, DOI: 10.1002/14651858.CD003053.pub5

  20. Ethinyl estradiol–drospirenone vs ethinyl estradiol–drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome

    Clinical Endocrinology

    Volume 78, Issue 3, March 2013, Pages: 379–384, Nese Cinar, Ayla Harmanci, Miyase Bayraktar and Bulent O. Yildiz

    Article first published online : 25 JAN 2013, DOI: 10.1111/j.1365-2265.2012.04415.x